Loading...

APC anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_APC_090507
C57BL/6 mouse splenocytes stained with RA3-6B2 APC
  • RA3-6B2_APC_090507
    C57BL/6 mouse splenocytes stained with RA3-6B2 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103211 25 µg 28 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103212 100 µg 88 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD45R antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  3. Hirata Y, et al. 2010. Blood. 115:3930. PubMed
  4. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  5. Noir S, et al. 2017. Nucleic Acids Res. 10.1093/nar/gkx203. PubMed
  6. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  7. Atalis A, et al. 2022. J Control Release. 347:476. PubMed
  8. Erickson JJ, et al. 2022. Nature. 606:769. PubMed
  9. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  10. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  11. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  12. Roberts JL, et al. 2022. Bone. 157:116310. PubMed
  13. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  14. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  15. Grenov A, et al. 2022. Cell Rep. 39:110778. PubMed
  16. Sia ZR, et al. 2022. J Virol. 96:e0100622. PubMed
  17. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  18. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  19. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  20. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  21. Wiedmann L, et al. 2023. Nat Commun. 14:2353. PubMed
  22. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  23. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  24. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  25. He R, et al. 2021. J Immunol. 206:2353. PubMed
  26. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  27. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  28. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  29. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  30. Li Y, et al. 2016. Nat Commun. 7:10836. PubMed
  31. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  32. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  33. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  34. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  35. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  36. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  37. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  38. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  39. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  40. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  41. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  42. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  43. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  44. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  45. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  46. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  47. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  48. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  49. Suzuki M, et al. 2021. Sci Adv. 7:. PubMed
  50. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  51. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  52. Cunningham C, et al. 2016. PLoS Pathog. 12: 1005356. PubMed
  53. Rothweiler S, et al. 2019. Purinergic Signal. 0.885416667. PubMed
  54. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  55. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  56. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  57. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  58. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  59. Fantauzzi MF, et al. 2021. ERJ Open Res. 7: . PubMed
  60. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  61. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  62. Perfilyeva Y, et al. 2017. Inflammation Research. 10.1007/s00011-017-1052-4. PubMed
  63. Recher M, et al. 2012. Blood. 119:2819. PubMed
  64. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  65. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  66. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  67. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  68. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  69. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  70. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  71. Cervantes-Barragan L, et al. 2007. Blood . 109:1131. PubMed
  72. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  73. Li J, et al. 2020. Elife. 9:00. PubMed
  74. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  75. Reddi RN, et al. 2021. J Am Chem Soc. 143:4979. PubMed
  76. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  77. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  78. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  79. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  80. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  81. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  82. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  83. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  84. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  85. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  86. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  87. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  88. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  89. Minamitani T, et al. 2015. Proc Natl Acad Sci U S A. 112: 11612-11617. PubMed
  90. Saintamand A, et al. 2016. Nat Commun. 7:10730. PubMed
  91. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  92. Reddi RN, et al. 2021. J Am Chem Soc. 143:20095. PubMed
  93. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  94. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  95. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  96. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  97. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  98. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  99. Braikia F, et al. 2015. Mol Cell Biol. 35: 3370 - 3380. PubMed
  100. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  101. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  102. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  103. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  104. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  105. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  106. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  107. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  108. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  109. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  110. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  111. Ma K, et al. 2022. iScience. 25:104347. PubMed
  112. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  113. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  114. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  115. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  116. Shih F, et al. 2006. J Immunol. 176:3438. PubMed
  117. Zhu D, et al. 2017. Stem Cell Res Ther. 0.511805556. PubMed
  118. Sato K, et al. 2017. J Immunol. 10.4049/jimmunol.1602005. PubMed
  119. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  120. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  121. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  122. Graf R et al. 2019. Cell reports. 26(5):1098-1103 . PubMed
  123. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  124. Escolano A, et al. 2019. Nature. 570:468. PubMed
  125. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  126. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  127. Fahey L, et al. 2011. J Exp Med. 208:987. PubMed
  128. Yammani R, et al. 2015. J Immunol. 193: 5434-5443. PubMed
  129. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  130. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  131. Koide S, et al. 2022. iScience. 25:103603. PubMed
  132. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  133. Laubreton D, et al. 2020. Viruses. 12:00. PubMed
  134. Feldman S, et al. 2015. J Immunol. 194:2380. PubMed
  135. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  136. Kim SK, et al. 2018. Genes Dev. 32:849. PubMed
  137. Bussey KA, et al. 2019. J Virol. 93. PubMed
  138. Li X, et al. 2018. Immunity. 48:530. PubMed
  139. Puget N, et al. 2015. Mol Cell Biol. 35:529. PubMed
  140. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  141. Odeh A Simecka J 2016. PLoS One. 11: 0155648. PubMed
  142. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  143. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  144. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  145. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  146. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  147. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  148. Li C, et al. 2021. Chem Biol Drug Des. 97:1151. PubMed
  149. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  150. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  151. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  152. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  153. Cooley L, et al. 2016. Sci Rep. 6: 25840. PubMed
  154. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  155. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  156. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  157. Perper SJ, et al. 2019. J Immunol. 203:58. PubMed
  158. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  159. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  160. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  161. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  162. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  163. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  164. Man N, et al. 2021. JCI Insight. 6:. PubMed
  165. Chirivi RGS, et al. 2020. Cell Mol Immunol. . PubMed
  166. Schaum N, et al. 2020. Nature. 583:596. PubMed
  167. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  168. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  169. Hohmann A, et al. 2016. Nat Chem Biol. 10.1038/nchembio.2115. PubMed
  170. Davidson M, et al. 2013. PLoS One. 8:76258. PubMed
  171. Zhang Y, et al. 2008. Mol Cell Biol. 28:1688. PubMed
  172. Finkin S et al. 2019. Immunity. 51(2):324-336 . PubMed
RRID
AB_312996 (BioLegend Cat. No. 103211)
AB_312996 (BioLegend Cat. No. 103212)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV395™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04.25.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account